Convatec Group
ConvaTec Group PLC is a United Kingdom-based medical technology enterprise specializing in chronic care management solutions. The company operates through four core business categories: Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, producing specialized dressings, ostomy pouches, catheters, and subcutaneous infusion sets. Principal revenue streams are derived from commercial product sales of medical consumables and specialized devices to hospitals, home healthcare agencies, and pharmacy channels. ConvaTec serves medical professionals, surgical centers, chronic care patients, and home healthcare users across Europe, North America, and international markets. The enterprise commands a premier global position as a specialized developer and manufacturer of advanced chronic care medical products. ConvaTec Group PLC is headquartered in Reading, United Kingdom, and its common shares are listed on the London Stock Exchange.
13 of the funds FundTelligence covers report a position in Convatec Group.
- Legal name
- CONVATEC GROUP PLC
- Sector
- Health Care
- Country
- United Kingdom
- Funds holding it
- 13
Funds holding Convatec Group
- FAST Global Fund — Fidelity · 4.9 % (largest positions only, October 2026)
- Nordea European Small and Mid Cap Sustainable Stars — Nordea Funds · 3.02 % (full portfolio disclosed, July 2026)
- SEB Europafond Småbolag — SEB · 2.14 % (full portfolio disclosed, June 2026)
- Nordea Europa — Nordea Funds · 1.58 % (full portfolio disclosed, September 2026)
- Nordea European Sustainable Stars — Nordea Funds · 1.58 % (full portfolio disclosed, September 2026)
- Lannebo Global Småbolag — Lannebo · 0.88 % (full portfolio disclosed, June 2026)
- DWS Invest ESG European Small/Mid Cap — DWS · 0.28 % (full portfolio disclosed, June 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.09 % (full portfolio disclosed, December 2025)
Showing the 8 largest of 13 funds holding it.